Ipamorelin (5/10mg) – Nordsci
US$ 29.23
cjc1295 no dac 5mg & ipamorelin 5mg CJC-1295 (NO DAC) + 5mg+5mg CJC 1295 No DAC 5mg/Ipamorelin
Description
In a follow-up trial conducted by the JPLSG between 2011 and 2015, allocation to HSCT in first CR was restricted to the patients with KMT2A rearrangements and classified as high risk (age 300,000/L or a prednisolone poor responder), the 5-year EFS rate was 45.2%
Martinez, V
Yang M, Pei B, Hu Q et al (2023) Effects of selenium supplementation on concurrent chemoradiotherapy in patients with cervical cancer: a randomized, double-blind, placebo-parallel controlled phase II clinical trial
P928, P929 Nasser M
& Fenicheil, P
